You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Geriatric assessment (GA) pre-transplant
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 24, 2022

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Neutrophilic Leukemia Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Neutrophilic Leukemia
  • Laboratory Biomarker Analysis
  • +3 more
  • Palo Alto, California
  • +6 more
Oct 22, 2020

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

    Recruiting
    • CML, Chronic Phase
    • CML, Accelerated Phase
    • HS-10382(Part 1: Dose escalation)
    • HS-10382(Part 2: Dose expansion)
    • Wuhan, Hubei, China
      Union Hospital affiliated to Tongji Medical College of Huazhong
    Jan 12, 2023

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jul 24, 2022

        Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

        Active, not recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
          • Jena, Germany
            University Hospital Jena
          Jan 17, 2023

          According to Molecular Identification at Diagnosis

          Not yet recruiting
          • Chronic Myeloid Leukemia
          • Next Generation Sequencing (DNA and RNA)
          • (no location specified)
          Oct 28, 2022

          Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

          Recruiting
          • Acute Biphenotypic Leukemia
          • +13 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 19, 2023

          Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

          Recruiting
          • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
          • Houston, Texas
            M D Anderson Cancer Center
          Feb 1, 2022

          B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

          Recruiting
          • B-cell Acute Lymphoblastic Leukemia
          • +2 more
          • Chicago, Illinois
          • +5 more
          Dec 27, 2021

          Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
          • Houston, Texas
            M D Anderson Cancer Center
          Jun 24, 2022

          Ponatinib in CML Patients in Chronic Phase

          Recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
          • Therapeutic drug monitoring
          • Molecular Response
          • Cagliari, Italy
          • +4 more
          Nov 3, 2023

          Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +2 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jun 15, 2022

          "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

          Not yet recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Sohag, Egypt
              Sohag University Hospital
            Sep 14, 2022

            Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

            Not yet recruiting
            • Acute Lymphoblastic Leukemia
            • +6 more
            • Miltenyi CliniMACS Prodigy ® system
            • (no location specified)
            Mar 23, 2023

            CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

            Recruiting
            • CML
            • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
            • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
              FUNDALEU
            Jun 29, 2023